Adjuvant immunotherapy for high-risk renal cell carcinoma—now or never?

Tivya Kulasegaran, Niara Oliveira, Craig Gedye, Shomik Sengupta

Eastern Health Clinical School

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	235-236
Number of pages	2
Journal	BJU International
Volume	135
Issue number	2
DOIs	https://doi.org/10.1111/bju.16584
Publication status	Published - Feb 2025

Access to Document

10.1111/bju.16584

Other files and links

Link to publication in Scopus

Cite this

@article{c51d342e7ab8455eb1e6dd71e9fe4e47,

title = "Adjuvant immunotherapy for high-risk renal cell carcinoma—now or never?",

author = "Tivya Kulasegaran and Niara Oliveira and Craig Gedye and Shomik Sengupta",

year = "2025",

month = feb,

doi = "10.1111/bju.16584",

language = "English",

volume = "135",

pages = "235--236",

journal = "BJU International",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Adjuvant immunotherapy for high-risk renal cell carcinoma—now or never?

AU - Kulasegaran, Tivya

AU - Oliveira, Niara

AU - Gedye, Craig

AU - Sengupta, Shomik

PY - 2025/2

Y1 - 2025/2

UR - https://www.scopus.com/pages/publications/85208585214

U2 - 10.1111/bju.16584

DO - 10.1111/bju.16584

M3 - Comment / Debate

C2 - 39513301

AN - SCOPUS:85208585214

SN - 1464-4096

VL - 135

SP - 235

EP - 236

JO - BJU International

JF - BJU International

IS - 2

ER -